Retinoic acid delivery via ultraflexible nanovesicular system for the management of posterior segment ocular diseases
Scripta Medica · 2026 · 57 (3) · 489-503
DOI: 10.5937/scriptamed57-60631 ↗Kurz gefasst
Fachartikel in der Zeitschrift Scripta Medica, 2026. Verfasst von Vandana Gupta und 4 weiteren Autor:innen. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Aim: Ophthalmic diseases, especially conditions of posterior segment of eye encompass a range of conditions affecting the vitreous, choroid and retina, resulting in both structural and functional deficiencies in the eye. This study aimed to formulate and evaluate ultraflexible nanovesicular systems (nano-transfersomes) for local delivery of retinoic acid to the deeper posterior regions of the eye.
Methods
Transfersome compositions were optimised and characterised for vesicle size and distribution, surface charge (zeta potential), encapsulation efficiency, surface morphology, viscosity and pH. Additional evaluations included in vitro drug release in simulated tear fluid (STF), threemonth stability testing, and ocular safety assessment using the hen's egg chorioallantoic membrane (HET-CAM) test.
Results
The optimised formulation (F12) had a mean vesicle diameter of 155.32 ± 4.45 nm, measured by dynamic light scattering (Malvern Zetasizer ZEM 5002, UK). The zeta potential was approximately -36.5 mV, indicating a negative surface charge and reduced particle aggregation. Entrapment efficiency across formulations ranged from 65.45 ± 1.27 % to 79.12 ± 2.23 %. Nano-transfersomes exhibited spherical, elastic morphology with unior multilamellar vesicle structures. Viscosity of the retinoic acid-loaded formulations ranged from 20.0 ± 2.1 to 48.0 ± 1.8 cP, and pH ranged from 5.0 ± 0.5 to 7 .0 ± 0.1. In STF, cumulative drug release reached 98.89 ± 0.45 % after 24 h.
Conclusion
Retinoic acid-loaded ultraflexible nano-transfersomes demonstrated a sustained release profile and greater stability under refrigerated conditions. The formulation showed suitable physicochemical properties for ocular application and may offer a promising approach to deliver retinoic acid to the posterior segment of the eye, owing to its flexibility, prolonged release and small size.
Zitieren
APA
Gupta, V., Srivastava, N., Verma, M., Beohar, M., & Verma, V. (2026). Retinoic acid delivery via ultraflexible nanovesicular system for the management of posterior segment ocular diseases. Scripta Medica, 57(3), 489-503. https://doi.org/10.5937/scriptamed57-60631
Vancouver
Gupta V, Srivastava N, Verma M, Beohar M, Verma V. Retinoic acid delivery via ultraflexible nanovesicular system for the management of posterior segment ocular diseases. Scripta Medica. 2026;57(3):489-503. doi:10.5937/scriptamed57-60631
BibTeX
@article{Gupta2026,
author = {Gupta, Vandana and Srivastava, Noopur and Verma, Megha and Beohar, Mahima and Verma, Vishal},
title = {Retinoic acid delivery via ultraflexible nanovesicular system for the management of posterior segment ocular diseases},
journal = {Scripta Medica},
year = {2026},
volume = {57},
number = {3},
pages = {489--503},
doi = {10.5937/scriptamed57-60631}
}
EUVIMED